Published on in Vol 10 (2024)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/60961, first published .
Preparing for the Implementation of Long-Acting Injectable Cabotegravir for HIV Pre-Exposure Prophylaxis Within the Brazilian Public Health System (ImPrEP CAB Brasil): Qualitative Study

Preparing for the Implementation of Long-Acting Injectable Cabotegravir for HIV Pre-Exposure Prophylaxis Within the Brazilian Public Health System (ImPrEP CAB Brasil): Qualitative Study

Preparing for the Implementation of Long-Acting Injectable Cabotegravir for HIV Pre-Exposure Prophylaxis Within the Brazilian Public Health System (ImPrEP CAB Brasil): Qualitative Study

M Cristina Pimenta   1 * , PhD ;   Thiago Silva Torres   1 * , PhD ;   Brenda Hoagland   1 , MD, PhD ;   Mirian Cohen   1 , PhD ;   Claudio Gruber Mann   1 , PhD ;   Cristina M Jalil   1 , MSc ;   Eduardo Carvalheira   1 , MSc ;   Lucilene Freitas   1 , PhD ;   Nilo Fernandes   1 , PhD ;   Debora Castanheira   1 , PhD ;   Marcos Benedetti   1 , MSc ;   Julio Moreira   2 , BA ;   Keila Simpson   3 , BA ;   Roberta Trefiglio   1 , BA ;   Gabrielle O’Malley   4 , PhD ;   Valdilea G Veloso   1 * , MD, PhD ;   Beatriz Grinsztejn   1 * , MD, PhD

1 Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil

2 Grupo Arco-Íris de Cidadania LGBT, Rio de Janeiro, Brazil

3 Associação Nacional de Travestis e Transexuais, Salvador, Brazil

4 Department of Global Health, Schools of Medicine and Public Health, University of Washington, Seattle, WA, United States

*these authors contributed equally

Corresponding Author:

  • Thiago Silva Torres, PhD
  • Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz
  • Av Brasil 4365 Manguinhos
  • Rio de Janeiro, RJ 21040-900
  • Brazil
  • Phone: 55 21 38659623
  • Email: thiago.torres@ini.fiocruz.br